Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


Uveitis Treatment Market in Europe is expected to register a CAGR of 5.02% during the forecast period (2019-2025) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Europe Uveitis Treatment Market, published by KBV research, the Europe Uveitis Treatment Market would witness market growth of 5.02% CAGR during the forecast period (2019-2025).

The Germany market is the one of the major revenue generating regions within the Europe Intermediate Uveitis Market by Country in 2018, growing at a CAGR of 4.7 % during the forecast period. The UK market is experiencing a CAGR of 4.7% during (2019 - 2025). Additionally, The France market is poised to grow at a CAGR of 6.4% during (2019 - 2025).

The Hospital Pharmacies market dominated the Spain Uveitis Treatment Market by Distribution Channel in 2018, thereby, achieving a market value of $5.5 million by 2025, growing at a CAGR of 5.3 % during the forecast period. The Retail Pharmacies market is expected to witness highest CAGR of 6.1% during (2019 - 2025).

The Anti-inflammatory market dominated the France Uveitis Treatment Market by Drug Class in 2018, growing at a CAGR of 5.2 % during the forecast period. The Immunotherapy & Targeted Therapies market is exhibiting a CAGR of 6% during (2019 - 2025).

Structural Insights: https://www.kbvresearch.com/europe-uveitis-treatment-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AbbVie, Inc., Alimera Sciences, Inc., Enzo Biochem, Inc., Amgen, Inc., Bausch Health Companies, Inc., Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., TopiVert Ltd., and Novartis AG.

Europe Uveitis Treatment Market Segmentation

By Drug Class

  • Anti-inflammatory
  • Immunotherapy & Targeted Therapies
  • Antimicrobial Drugs
  • Other Drug Class

By Disease Type

  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online stores

By Country

  • Germany Uveitis Treatment Market
  • UK Uveitis Treatment Market
  • France Uveitis Treatment Market
  • Russia Uveitis Treatment Market
  • Spain Uveitis Treatment Market
  • Italy Uveitis Treatment Market
  • Rest of Europe Uveitis Treatment Market

Companies Profiled

  • AbbVie, Inc.
  • Alimera Sciences, Inc.
  • Enzo Biochem, Inc.
  • Amgen, Inc.
  • Bausch Health Companies, Inc.
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • TopiVert Ltd.
  • Novartis AG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Uveitis Treatment Market Related Reports:

Global Market

North America Market

Asia Pacific Market

LAMEA Market



SUBSCRIPTION MODEL